Comparison of IgM-MGUS and IgG-MGUS polyneuropathy

Acta Neurologica Scandinavica

Volumn 97, Issue 3, 1998, Pages 194-200

  Simovic, D ^a   Gorson, K C ^a,b   Ropper, A H ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

MAG; MGUS; Monoclonal gammopathy; Neuropathy; Paraprotein

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARAPROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; ELECTRODIAGNOSIS; ELECTROMYOGRAPHY; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; NERVE CONDUCTION; PERONEUS NERVE; PLASMAPHERESIS; POLYNEUROPATHY;

EID: 0031799535     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1998.tb00636.x     Document Type: Article

References (41)

1. KELLY JJ JR., KYLE RA, O'BRIEN PC, DYCK PJ. Prevalence of monoclonal protein in peripheral neuropathy. Neurology 1981: 31: 1480-3.
2. KYLE RA, DYCK PJ. Neuropathy associated with monoclonal gammopathies. In: In: DYCK PJ, THOMAS PK, GRIFFIN JW, LOW PA, PODULOS JF, eds. Peripheral Neuropathy, 3rd edition. Philadelphia: WB Saunders, 1993: 1275-87.
3. KELLY JJ JR. Peripheral neuropathies associated with monoclonal proteins: a clinical review. Muscle Nerve 1985: 8: 138-50.
4. KISSEL JT, MENDELL JR. Neuropathies associated with monoclonal gammopathies. Neuromuscul Disord 1995: 6: 3-18.
5. KELLY JJ, ADELMAN LS, BERKMAN E, BHAN I. Polyneuropathies associated with IgM monoclonal gammopathies. Arch Neurol 1988: 45: 1355-9.
6. ELLIE E, VITAL A, STECK A et al. Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological, pathological findings and response to treatment in 33 cases. J Neurol 1996: 243: 34-43.
7. SMITH IS. The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinemia. Brain 1994: 117: 949-57.
8. NOTERMANS NC, WOKKE JHJ, LOKHORST HM et al. Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities. Brain 1994: 117: 1385-93.
9. SUAREZ GA, KELLY J. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: Further evidence that IgM-MGUS neuropathies are different than IgG-MGUS. Neurology 1993: 43: 1304-8.
10. GOSSELIN S, KYLE RA, DYCK PJ. Neuropathy associated with monoclonal gammopathies of undetermined significance. Ann Neurol 1991: 30: 54-61.
11. DYCK PJ, LOW PA, WINDEBANK AJ et al. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 1991: 325: 1482-6.
12. NOBILE-ORAZIO E, BARBIERI S, BALDINI L et al. Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenic studies. Acta Neurol Scand 1992: 85: 383-90.
13. KELLY JJ. The electrodiagnostic findings in polyneuropathies associated with IgM monoclonal gammopathies. Muscle Nerve 1990: 13: 1113-17.
14. YEUNG KB, THOMAS PK, KING RHM et al. The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinemia. J Neurol 1991: 238: 383-91.
15. SIMMONS Z, ALBERS JW, BROMBERG MB et al. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 1993: 43: 2202-9.
16. BROMBERG MB, FELDMAN EL, ALBERS JW. Chronic inflammatory demyelinating polyneuropathy: comparison of patients with and without an associated monoclonal gammopathy. Neurology 1992: 42: 1157-63.
17. SIMMONS Z, ALBERS JW, BROMBERG MB, FELDMAN EL. Long-term follow-up of patients with chronic inflammatory demyelinating polyneuropathy, without and with monoclonal gammopathy. Brain 1995: 118: 359-68.
18. LATOV N, HAYS AP, SHERMAN WH. Peripheral neuropathy and anti-MAG antibodies. CRC Crit Rev Neurobiology 1988: 3: 301-32.
19. LATOV N. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies. Ann Neurol 1995: 37 (Suppl. 1): S32-S42.
20. HAFLER DA, JOHNSON D, KELLY JJ, PANITCH H, KYLE R, WEINER HL. Monoclonal gammopathy and neuropathy: Myelin-associated glycoprotein reactivity and clinical characteristics. Neurology 1986: 36: 75-8.
21. TROJABORG W, HAYS AP, VAN DEN BERG L, YOUNGER DS, LATOV N. Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies. Muscle Nerve 1995: 18: 730-5.
22. KAKU DA, ENGLAND JD, SUMNER AJ. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain 1994: 117: 941-7.
23. ALBERS JW, KELLY JJ. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 1989: 12: 435-51.
24. PESTRONK A, LI F, GRIFFIN J et al. Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein. Neurology 1991: 41: 357-62.
25. MENDELL JR, SARENK Z, WHITAKER JN et al. Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenic role of anti-myelin-associated glycoprotein antibody. Ann Neurol 1985: 17: 243-54.
26. VITAL A, VITAL C, JULIEN J et al. Polyneuropathy associated with IgM monoclonal gammopathy: immunological and pathological study in 31 patients. Acta Neuropathol 1989: 79: 160-7.
27. TAKATSU M, HAYS AP, LATOV N et al. Immunofluorescence study of patients with neuropathy and IgM M proteins Ann Neurol 1985: 18: 173-81.
28. HAYS AP, LATOV N, TAKATSU M et al. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology 1987: 37: 242-56.
29. WILLISON HJ, TRAPP BD, BACHER JD et al. Demyelination induced by intraneural injection of human anti-myelin associated glycoprotein antibodies. Muscle Nerve 1988: 11: 1169-76.
30. TROJABORG W, GALLASSI G, HAYS AP et al. Electrophysiologic study of experimental demyelination induced by serum of patients with IgM M protein and neuropathy. Neurology 1989: 39: 1581-6.
31. NOTERMANS NC, LOKHORST HM, FRANSSEN H et al. Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance. Neurology 1996: 47: 1227-33.
32. SHERMAN WH, OLARTE MR, MCKIERNAN G, SWEENEY K, LATOV N, HAYS AP. Plasma exchange treatment of peripheral neuropathy associated with plasma cell dyscrasia. J Neurol Neurosurg Psychiatry 1984: 47: 813-9.
33. FINEMAN SM, MCKENDALL RR. Plasma exchange: a treatment for neuropathy associated with IgG-kappa gammopathy. J Neurol 1990: 237: 85-7.
34. ERNERUDH J, BRODTKORB E, OLSSON T et al. Peripheral neuropathy and monoclonal IgM with antibody activity against peripheral nerve myelin; effect of plasma exchange. J Neuroimmunol 1986: 11: 171-8.
35. HOANG-XUAN K, LEGER JM, YOUNES-CHENNOUFI AB et al. Traitement des neuropathies dysimmunitaires par immunoglobulines polyvalentes intraveineuses. Etude ouverte de 16 cas. Rev Neurol (Paris) 1993: 149: 385-92.
36. COOK D, DALAKAS M, GALDI A et al. High dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated monoclonal gammopathy. Neurology 1990: 40: 212-14.
37. DALAKAS MC, ENGEL W. Polyneuropathy with monoclonal gammopathy: study of 11 patients. Ann Neurol 1981: 10: 45-52.
38. NOBILE-ORAZIO E, BALDINI L, BARBIERI S et al. Treatment of patients with neuropathy and anti-MAG IgM M-proteins. Ann Neurol 1988: 24: 83-97.
39. BLUME G, PESTRONK A, GOODNOUGH LT. Anti-MAG antibody associated polyneuropathies: Improvement following immunotherapy with monthly plasma exchange and IV cyclophosphamide. Neurology 1995: 45: 1577-80.
40. THOMPSON N, CHOUDHARY P, HUGHES RAC, QUINLIVAN RM. A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol 1996: 243: 280-5.
41. DALAKAS MC, QUARLES RH, FARRER RG et al. A controlled study of intravenous gammaglobulin in demyelinating neuropathy with IgM gammopathy. Ann Neurol 1996: 40: 792-5.